Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Scios Inc.

Division of Johnson & Johnson
www.sciosinc.com

Latest From Scios Inc.

Califf’s Trial Design Prescription: Less Randomization, More Transparency

FDA’s new deputy commissioner is expected to advocate for innovation in clinical studies; Duke cardiologist has led numerous trials, including pivotal Xarelto study and Vytorin outcomes trial.

BioPharmaceutical Regulation

Expert Urges Companies to Heed Whistleblowers

As manufacturers come under more scrutiny for fraud from the federal government, David Marshall, an attorney who specializes in whistleblower cases, says companies that deal with non-compliance issues early are much more likely to get lenient treatment than those who try covering them up.

BioPharmaceutical Medical Device

Expert Urges Companies to Heed Whistleblowers

As device makers come under more scrutiny for fraud from the federal government, David Marshall, an attorney who specializes in whistleblower cases, says companies that deal with non-compliance issues early are much more likely to get lenient treatment than those who try covering them up.

Medical Device Compliance

J&J Risperdal Off-Label Settlement Includes Exec Pay Recoupment Provision

Janssen subsidiary pleads guilty as part of $2.2 billion deal that also requires audits of sales rep compensation.

BioPharmaceutical United States
See All

Company Information

Advertisement
Advertisement
UsernamePublicRestriction

Register